$STML STEMLINE THERAPEUTICS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in STEMLINE THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in STEMLINE THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in STEMLINE THERAPEUTICS INC for free.

CIK Number: 0001264587
IRS Number: 450522567
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: STML
Company Address: 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK 10022
Phone number: 212-531-5969

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in a solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.

Market Capitalization: $118.68M
Prev close: $6.20
Average Daily Volume: 325,710
Days Low: $6.00
Year Low: $3.88
Year High: $14.60

STEMLINE THERAPEUTICS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Bergstein IvanChief Executive Officer2,664,27816,518,524shares bought: 1,036,750 / shares sold: -227,551 STRONG BUYMar 15 20191 month ago
Gionco DavidChief Accounting Officer225,4681,397,902shares bought: 201,450 / shares sold: -73,122 STRONG BUYMar 15 20191 month ago
Hoberman KennethChief Operating Officer756,6774,691,397shares bought: 625,450 / shares sold: -175,373 STRONG BUYMar 15 20191 month ago

View all STEMLINE THERAPEUTICS INC insiders.

STEMLINE THERAPEUTICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 15 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...SellS11.052,15123,7692,662,1272.7 M to 2.7 M (-0.08 %)
Mar 15 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...SellS11.1155,073611,8612,664,2782.7 M to 2.7 M (-2.03 %)
Mar 15 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS11.0498110,830755,696756.7 K to 755.7 K (-0.13 %)
Mar 15 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS11.1125,101278,872756,677781.8 K to 756.7 K (-3.21 %)
Mar 15 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...SellS11.055305,857224,938225.5 K to 224.9 K (-0.24 %)
Mar 15 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...SellS11.1113,492149,896225,468239 K to 225.5 K (-5.65 %)
Mar 08 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS11.362,99534,023781,778784.8 K to 781.8 K (-0.38 %)
Mar 08 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS11.362,99534,023781,778784.8 K to 781.8 K (-0.38 %)
Mar 08 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...SellS11.321,38115,633238,960240.3 K to 239 K (-0.57 %)
Mar 08 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...SellS11.321,38115,633238,960240.3 K to 239 K (-0.57 %)
Mar 08 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...SellS11.416,80077,5882,719,3512.7 M to 2.7 M (-0.25 %)
Mar 08 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...SellS11.416,80077,5882,719,3512.7 M to 2.7 M (-0.25 %)
Feb 27 2019STMLSTEMLINE THERAPEUT ...Gionco DavidChief Accounting Of ...SellS12.038,563103,013240,341248.9 K to 240.3 K (-3.44 %)
Feb 27 2019STMLSTEMLINE THERAPEUT ...Hoberman KennethChief Operating Off ...SellS12.0510,557127,212784,773795.3 K to 784.8 K (-1.33 %)
Feb 27 2019STMLSTEMLINE THERAPEUT ...Bergstein IvanChief Executive Off ...SellS12.0322,905275,5472,726,1512.7 M to 2.7 M (-0.83 %)

View all STEMLINE THERAPEUTICS INC insider transactions.